These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 11904335

  • 21. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J.
    Oncogene; 1999 Jul 08; 18(27):4044-6. PubMed ID: 10435629
    [Abstract] [Full Text] [Related]

  • 22. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, Helmke BM.
    Genes Chromosomes Cancer; 2004 Oct 08; 41(2):93-8. PubMed ID: 15287021
    [Abstract] [Full Text] [Related]

  • 23. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
    Chetty R, Serra S, Salahshor S, Alsaad K, Shih W, Blaszyk H, Woodgett JR, Tsao MS.
    Hum Pathol; 2006 Feb 08; 37(2):212-7. PubMed ID: 16426922
    [Abstract] [Full Text] [Related]

  • 24. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
    Schlosshauer PW, Pirog EC, Levine RL, Ellenson LH.
    Mod Pathol; 2000 Oct 08; 13(10):1066-71. PubMed ID: 11048799
    [Abstract] [Full Text] [Related]

  • 25. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA.
    Oncogene; 2000 Jan 27; 19(4):498-504. PubMed ID: 10698519
    [Abstract] [Full Text] [Related]

  • 26. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
    Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT.
    Proc Natl Acad Sci U S A; 2001 Dec 18; 98(26):14973-8. PubMed ID: 11752446
    [Abstract] [Full Text] [Related]

  • 27. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
    Liu S, Daa T, Kashima K, Kondoh Y, Yokoyama S.
    J Cutan Pathol; 2007 Jan 18; 34(1):22-6. PubMed ID: 17214850
    [Abstract] [Full Text] [Related]

  • 28. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
    Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC.
    Oncogene; 1999 Aug 19; 18(33):4726-33. PubMed ID: 10467420
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
    Ikeda S, Ishizaki Y, Shimizu Y, Fujimori M, Ojima Y, Okajima M, Sugino K, Asahara T.
    Int J Oncol; 2002 Mar 19; 20(3):463-6. PubMed ID: 11836555
    [Abstract] [Full Text] [Related]

  • 30. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Grieco M, Ramires P, Romito AM, De Rosa G, Piattelli A.
    Anticancer Res; 2002 Mar 19; 22(2A):565-76. PubMed ID: 12014624
    [Abstract] [Full Text] [Related]

  • 31. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S, Azzoni C, Tamburini E, Bottarelli L, Campanini N, D'Adda T, Fellegara G, Luong TV, Pasquali C, Rossi G, Delle Fave G, Camisa R, Bordi C, Rindi G.
    Endocr Relat Cancer; 2008 Dec 19; 15(4):1013-24. PubMed ID: 18632876
    [Abstract] [Full Text] [Related]

  • 32. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ.
    Mod Pathol; 2002 Apr 19; 15(4):454-61. PubMed ID: 11950921
    [Abstract] [Full Text] [Related]

  • 33. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
    Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL.
    J Pathol; 2002 Feb 19; 196(2):145-53. PubMed ID: 11793365
    [Abstract] [Full Text] [Related]

  • 34. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL, Chen YT, Yantiss RK.
    Am J Surg Pathol; 2008 Sep 19; 32(9):1388-95. PubMed ID: 18670349
    [Abstract] [Full Text] [Related]

  • 35. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R, Zhai Y, Fearon ER, Cho KR.
    Cancer Res; 2001 Nov 15; 61(22):8247-55. PubMed ID: 11719457
    [Abstract] [Full Text] [Related]

  • 36. Regulation of beta-catenin signaling in the Wnt pathway.
    Kikuchi A.
    Biochem Biophys Res Commun; 2000 Feb 16; 268(2):243-8. PubMed ID: 10679188
    [Abstract] [Full Text] [Related]

  • 37. The significance of the Wnt pathway in the pathology of human cancers.
    Karim R, Tse G, Putti T, Scolyer R, Lee S.
    Pathology; 2004 Apr 16; 36(2):120-8. PubMed ID: 15203747
    [Abstract] [Full Text] [Related]

  • 38. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
    Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, Lin CC.
    Int J Oncol; 2003 Oct 16; 23(4):1001-7. PubMed ID: 12963979
    [Abstract] [Full Text] [Related]

  • 39. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, Hahnen E, Kreutzer J, Fahlbusch R.
    Acta Neuropathol; 2005 Jun 16; 109(6):589-97. PubMed ID: 15891929
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas.
    Tokumoto N, Ikeda S, Ishizaki Y, Kurihara T, Ozaki S, Iseki M, Shimizu Y, Itamoto T, Arihiro K, Okajima M, Asahara T.
    Int J Oncol; 2005 Oct 16; 27(4):973-80. PubMed ID: 16142313
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.